MINUTOLO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 5.414
EU - Europa 4.648
AS - Asia 886
SA - Sud America 16
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 10.990
Nazione #
US - Stati Uniti d'America 5.398
IE - Irlanda 1.655
UA - Ucraina 836
GB - Regno Unito 644
CN - Cina 425
IT - Italia 415
DE - Germania 354
SG - Singapore 236
SE - Svezia 225
FI - Finlandia 212
TR - Turchia 165
GR - Grecia 130
FR - Francia 47
BE - Belgio 37
RU - Federazione Russa 34
CZ - Repubblica Ceca 23
CA - Canada 12
IR - Iran 12
PH - Filippine 11
KR - Corea 10
NL - Olanda 10
ES - Italia 9
EU - Europa 7
IN - India 5
SC - Seychelles 5
CL - Cile 4
HK - Hong Kong 4
BR - Brasile 3
CO - Colombia 3
HU - Ungheria 3
ID - Indonesia 3
JP - Giappone 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
BD - Bangladesh 2
BG - Bulgaria 2
EG - Egitto 2
KZ - Kazakistan 2
MA - Marocco 2
MX - Messico 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
RS - Serbia 2
RW - Ruanda 2
TH - Thailandia 2
UG - Uganda 2
VN - Vietnam 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
HR - Croazia 1
KE - Kenya 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 10.990
Città #
Dublin 1.654
Jacksonville 1.275
Chandler 923
Chicago 466
Princeton 249
Wilmington 226
Medford 213
Roxbury 154
Boardman 150
Ann Arbor 139
Falls Church 133
San Mateo 125
Singapore 122
Beijing 101
Woodbridge 97
Nanjing 57
Bremen 56
Caserta 54
New York 53
Des Moines 52
Cambridge 41
Jinan 38
Brussels 37
Saint Petersburg 32
Houston 30
Mountain View 28
Norwalk 26
Napoli 25
Shenyang 23
Brno 22
Naples 21
Zhengzhou 21
Ashburn 18
Milan 17
Ningbo 13
Tianjin 13
Auburn Hills 12
Guangzhou 12
Rome 12
San Francisco 12
Los Angeles 11
Nanchang 11
Changsha 10
Hangzhou 10
Seattle 10
Taizhou 10
Zanjan 10
Helsinki 9
Munich 9
Redwood City 9
Düsseldorf 8
Hebei 8
Jiaxing 8
Kunming 8
Lanzhou 8
Taiyuan 8
Castel Volturno 7
Florence 7
Lappeenranta 7
Haikou 6
Ottawa 6
Shanghai 6
Fairfield 5
Melito di Napoli 5
Aversa 4
Bologna 4
Cantù 4
Cattolica 4
Frankfurt am Main 4
Groningen 4
London 4
Torino 4
Catania 3
Dearborn 3
Edinburgh 3
Hanover 3
Hong Kong 3
Madrid 3
Modena 3
Padova 3
Potenza 3
Prilep 3
Quezon City 3
Sacramento 3
Santiago 3
Turin 3
Verona 3
Aci Catena 2
Amsterdam 2
Atlanta 2
Bekasi 2
Bitlis 2
Bogotá 2
Brusciano 2
Cagliari 2
Calgary 2
Caloocan City 2
Casablanca 2
Castelnuovo Rangone 2
Cesena 2
Totale 7.051
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 769
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 115
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 90
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 78
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 76
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 72
Empagliflozin in Patients with Chronic Kidney Disease 70
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 70
[Anti-diabetics and chronic kidney disease] 69
Daily nutrient intake in hemodialysis. 68
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 66
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 66
Amino acid loss during dialysis treatment 66
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 65
Epidemiology of chronic kidney disease in Italy: the CARHES study 65
Inibizione dell’angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale 65
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 65
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 65
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 63
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 61
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 61
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 60
Effetto antiproteinurico di ACE inibitori e Losartan e polimorfismo del gene dell’ACE 60
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 59
Management of hypertension in chronic kidney disease: the Italian multicenter study. 57
Epidemiology of chronic kidney disease in Italy. J Nephrol 2010;23 (Suppl 15):S16-22 57
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 56
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 56
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 55
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 55
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 55
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 55
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 55
Effects of efficiency and length of acetate-free biofiltration session on post-dialysis solutes rebound 55
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 55
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 55
Management of hypertension in chronic kidney disease: the italian multicentric study 54
Management of hypertension in chronic kidney disease 54
Disfunzione renale nell’anziano: processo fisiologico o malattia? 54
Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? 54
Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-up 54
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 53
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 53
Heart Failure in chronic kidney disease: from epidemiology to therapy. 53
Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care 53
CALCOLOSI RENALE 53
Epidemiology of CKD Regression in Patients under Nephrology Care 53
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 52
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 52
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 52
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 52
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 52
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 51
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 51
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 51
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 51
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. 51
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 51
Effect of a low- versus moderate-protein diet on progression of CKD: Follow-up of a randomized controlled trial 50
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 50
Stability of target hemoglobin levels during the first year of epoetin treatment in CKD patients. 50
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 50
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 50
Manuale di Terapia delle Malattie Renali 50
[Iron deficiency in ND-CKD: from diagnosis to treatment] 50
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 49
Hyponatremia secondary to inappropriate antidiuretic hormone secretion. 49
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 49
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 49
[Hyperuricaemia and Chronic Kidney Disease] 49
Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study 48
Intradialytic changes of plasma amino acid levels: effect of hemodiafiltration with endogenous reinfusion versus acetate-free biofiltration 48
Epidemiology of chronic kidney disease in Italy 48
[Epidemiology and prognosis of chronic kidney disease in Italy] 48
AISF position paper on HCV in immunocompromised patients 48
Epoetin therapy and hemoglobin level variability in non-dialysis CKD patients 47
Sodium/Glucose Cotransporter 2 Inhibitors and Prevention of Diabetic Nephropathy: Targeting the Renal Tubule in Diabetes 47
Effects of age on hypertensive status in patients with chronic kidney disease 47
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 47
Patogenesi del rebound post-dialitico del fosforo 47
Resistant hypertension in nondialysis chronic kidney disease. 47
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 47
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 46
Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes 46
Hypertension in patients on hemodialysis: the role of salt intake. 46
Ruolo dell'endotelina-1 nelle modificazioni acute dell'emodinamica renale da mezzo di contrasto in pazienti con ridotta funzione renale 46
Aumento della reattività vascolare in risposta a variazioni del flusso in arterie mesenteriche di ratto isolate e perfuse 46
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice. 46
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 46
Responsiveness to erythropoiesis-stimulating agents in chronic kidney disease: does geography matter? 45
Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial 45
Clinical policies on the management of chronic kidney disease patients in Italy 45
Epoetin therapy and hemoglobin level variability in nondialysis patients with chronic kidney disease 45
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 45
Diagnostic role of ambulatory blood pressure monitoring in non-dialysis CKD patients 45
Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients. 45
Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study. 45
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 45
Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial 44
Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study. 44
Totale 6.163
Categoria #
all - tutte 45.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.313 323 235 9 11 223 14 251 22 120 47 47 11
2020/20211.859 177 14 224 137 358 8 240 203 17 251 179 51
2021/20221.805 158 42 46 74 539 15 37 51 65 146 161 471
2022/20233.672 323 110 313 299 343 307 11 219 1.567 36 65 79
2023/20241.271 121 45 54 118 464 68 45 20 20 23 86 207
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 11.336